Ionis Pharmaceuticals (IONS) News Today $41.73 -0.65 (-1.53%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$42.30 +0.57 (+1.37%) As of 08:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IONS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period IONS - Ionis Pharmaceuticals Inc Valuation - MorningstarJuly 10, 2025 | morningstar.comMIonis Pharmaceuticals, Inc. (IONS) - Yahoo FinanceJuly 8, 2025 | finance.yahoo.comDAVENPORT & Co LLC Sells 6,347 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)July 6, 2025 | marketbeat.comTeacher Retirement System of Texas Increases Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)July 5, 2025 | marketbeat.comIonis Pharmaceuticals (IONS) Moves 9.1% Higher: Will This Strength Last? - NasdaqJuly 5, 2025 | nasdaq.comSumitomo Mitsui Trust Group Inc. Sells 14,224 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)July 5, 2025 | marketbeat.com10 Analysts Assess Ionis Pharmaceuticals: What You Need To KnowJuly 3, 2025 | nasdaq.comIonis Pharmaceuticals (NASDAQ:IONS) Trading 7.9% Higher - Here's What HappenedJuly 2, 2025 | marketbeat.comBarclays Upgrades Ionis Pharmaceuticals (IONS)July 2, 2025 | msn.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 2, 2025 | marketbeat.comIonis Pharmaceuticals (NASDAQ:IONS) Rating Increased to Overweight at BarclaysJuly 1, 2025 | marketbeat.comIonis: After Years Of Investment, The Wholly-Owned Payoff Is In SightJune 29, 2025 | seekingalpha.comSovran Advisors LLC Purchases 157,092 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)June 29, 2025 | marketbeat.comBiogen Advances Once-Yearly SMA Therapy Salanersen to Phase 3 After Positive Phase 1 ResultsJune 28, 2025 | msn.comIONS - Ionis Pharmaceuticals Inc Sustainability - MorningstarJune 26, 2025 | morningstar.comMIonis Pharmaceuticals (NASDAQ:IONS) Given Buy Rating at HC WainwrightJune 26, 2025 | marketbeat.comIonis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 resultsJune 25, 2025 | businesswire.comIONS - Ionis Pharmaceuticals Inc Executives - MorningstarJune 24, 2025 | morningstar.comMIonis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to RetireJune 20, 2025 | msn.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Acquired by GAMMA Investing LLCJune 17, 2025 | marketbeat.comIonis announces Dr. Richard Geary, chief development officer, to retire; Dr. Holly Kordasiewicz to assume role in January 2026June 12, 2025 | finance.yahoo.com5IONS : Analyst Expectations For Ionis Pharmaceuticals's FutureJune 12, 2025 | benzinga.comJPMorgan Chase & Co. Raises Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $48.00June 12, 2025 | marketbeat.comFirst patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndromeJune 11, 2025 | finance.yahoo.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 7, 2025 | marketbeat.comCalifornia State Teachers Retirement System Acquires 7,722 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)June 3, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $21.66 Million Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 29, 2025 | marketbeat.comNuveen Asset Management LLC Trims Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 29, 2025 | marketbeat.comVoloridge Investment Management LLC Sells 63,698 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 27, 2025 | marketbeat.comWoodline Partners LP Purchases New Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 27, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Reduces Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 26, 2025 | marketbeat.comDecember 2027 Options Now Available For Ionis Pharmaceuticals (IONS)May 25, 2025 | nasdaq.comIonis Pharmaceuticals (NASDAQ:IONS) Earns "Buy" Rating from HC WainwrightMay 22, 2025 | marketbeat.comTwo Sigma Advisers LP Boosts Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 22, 2025 | marketbeat.comMillennium Management LLC Raises Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 22, 2025 | marketbeat.comVestal Point Capital LP Acquires New Shares in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 21, 2025 | marketbeat.com6IONS : Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 14...May 20, 2025 | benzinga.comTanaka Capital Management Inc. Decreases Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 20, 2025 | marketbeat.comTema Etfs LLC Purchases New Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 20, 2025 | marketbeat.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Bought by Rafferty Asset Management LLCMay 20, 2025 | marketbeat.comIonis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglyceridesMay 19, 2025 | finance.yahoo.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Ensign Peak Advisors IncMay 18, 2025 | marketbeat.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Holdings Boosted by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLCMay 15, 2025 | marketbeat.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Holdings Raised by Orbimed Advisors LLCMay 15, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Sells 368,966 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 15, 2025 | marketbeat.comIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 15, 2025 | marketbeat.comJ. Goldman & Co LP Increases Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 13, 2025 | marketbeat.comHudson Bay Capital Management LP Boosts Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 13, 2025 | marketbeat.comNorthern Trust Corp Buys 97,367 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 13, 2025 | marketbeat.comDriehaus Capital Management LLC Sells 49,967 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)May 12, 2025 | marketbeat.com Get Ionis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter. Email Address IONS Media Mentions By Week IONS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IONS News Sentiment▼0.911.01▲Average Medical News Sentiment IONS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IONS Articles This Week▼38▲IONS Articles Average Week Get Ionis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIIB News Today UTHR News Today INCY News Today NBIX News Today EXEL News Today BMRN News Today EXAS News Today RGEN News Today HALO News Today MDGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IONS) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ionis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
